Breccia Massimo, Petti Maria Concetta, D'Elia Gianna Maria, D'Andrea Mariella, Carmosino Ida, Alimena Giuliana
Department of Cellular Biotechnology and Hematology, University La Sapienza, Via Benevento 6, Rome, Italy.
Eur J Haematol. 2002 Jan;68(1):1-3. doi: 10.1034/j.1600-0609.2002.00596.x.
The coexistence of a primary myelodysplastic syndrome (MDS) and a T-cell cutaneous non-Hodgkin's lymphoma is an extremely rare event, which has so far only been reported in a single instance in the literature. We describe herein an additional case in which the lymphoid disease was combined with an MDS at the time of its evolution into acute myeloid leukemia (AML). Both diseases were successfully treated with a regimen containing fludarabine. We discuss possible pathogenetic mechanisms and suggest the use of nonalkylating drugs, such as fludarabine, for the treatment of this rare association of malignancies usually characterized by a very poor response to therapy.
原发性骨髓增生异常综合征(MDS)与T细胞皮肤非霍奇金淋巴瘤并存是一种极其罕见的情况,迄今为止文献中仅报道过一例。我们在此描述另外一例,该淋巴系统疾病在演变为急性髓系白血病(AML)时合并了MDS。两种疾病均通过含氟达拉滨的方案成功治疗。我们讨论了可能的发病机制,并建议使用非烷化药物,如氟达拉滨,来治疗这种罕见的恶性肿瘤关联,这类关联通常对治疗反应很差。